FDA Grant Symbicort Six Months Exclusivity

News   Jan 30, 2017

 
FDA Grant Symbicort Six Months Exclusivity
 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Biogen's MS Drug FAMPYRA Granted Standard Marketing Authorization in EU

News

Biogen's drug FAMPYRA improves walking for MS sufferers and has been granted standard marketing authorization.

READ MORE

Cost-Efficient Chemical Reaction Could Yield New Fuels and Medications

News

UCLA scientists have developed a novel and inexpensive chemical reaction that can cut carbon-hydrogen bonds and incorporate methane into larger molecules.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE